46,95 €
46,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
23 °P sammeln
46,95 €
46,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
23 °P sammeln
Als Download kaufen
46,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
23 °P sammeln
Jetzt verschenken
46,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
23 °P sammeln
  • Format: PDF

Single-arm phase II trial is a key component for developing advanced cancer drug and treatment to target therapy and immunotherapy in which time-to-event endpoints are the primary endpoints. The proposed book provides a comprehensive summary to the most commonly used methods for single-arm phase II trial design with time-to-event endpoints.

Produktbeschreibung
Single-arm phase II trial is a key component for developing advanced cancer drug and treatment to target therapy and immunotherapy in which time-to-event endpoints are the primary endpoints. The proposed book provides a comprehensive summary to the most commonly used methods for single-arm phase II trial design with time-to-event endpoints.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Jianrong (John) Wu is a professor in the Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky; Biostatistics and Bioinformatics Shared Resource, Markey Cancer Center. Dr. Wu has more than 20 years' experience of designing and conducting cancer clinical trials at St. Jude Children's Research Hospital and Markey Cancer Center and has developed many novel statistical methods for designing and monitoring single-arm phase II and randomized phase III trial design with time-to-event endpoints.